Researcher
Giuseppe Fasolino
- Keywords:Medicine
- Disciplines:Ophtalmology
Affiliations
- Faculty of Medicine and Pharmacy (Faculty)
Member
From8 Oct 2019 → Today - Ophtalmology - Eye surgery (Department)
Member
From1 Jan 2018 → Today - Surgical clinical sciences (Department)
Member
From1 Aug 2021 → Today
Publications
1 - 8 of 8
- A lead-in safety study followed by a phase 2 clinical trial of dabrafenib, trametinib and hydroxychloroquine in advanced BRAFV600 mutant melanoma patients previously treated with BRAF-/MEK-inhibitors and immune checkpoint inhibitors(2022)
Authors: Gil Awada, Julia K Schwarze, Jens Tijtgat, Giuseppe Fasolino, Vibeke Kruse, Bart Neyns
Pages: 183-191 - Choroidal and Choriocapillaris Morphology in Pan-FGFR Inhibitor-Associated Retinopathy: A Case Report(2022)
Authors: Giuseppe Fasolino, Pieter Nelis, Marcel Ten Tusscher, Laura Moschetta, Jacques De Greve, Pierre Lefesvre
Pages: 1-7 - Choriocapillaris Assessment In Patients Under Mek-Inhibitor Therapy For Cutaneous Melanoma(2021)
Authors: Giuseppe Fasolino, Gil Awada, Jorgos Koulalis, Bart Neyns, Peter Van Elderen, Robert Kuijpers, Pieter Nelis, Marcel Ten Tusscher
Pages: 765-771 - Non-arteritic anterior ischaemic optic neuropathy sequential to SARS-CoV-2 virus pneumonia(2021)
Authors: Laura Moschetta, Giuseppe Fasolino, Robert Kuijpers
- Acute exudative polymorphous vitelliform maculopathy during pembrolizumab treatment for metastatic melanoma(2021)
Authors: Ine Lambert, Giuseppe Fasolino, Gil Awada, Robert Kuijpers, Marcel Ten Tusscher, Bart Neyns
- A Phase 2 Clinical Trial of Trametinib and Low-Dose Dabrafenib in Patients with Advanced Pretreated NRASQ61R/K/L Mutant Melanoma (TraMel-WT)(2021)
Authors: Gil Awada, Julia K Schwarze, Jens Tijtgat, Giuseppe Fasolino, Hendrik Everaert, Bart Neyns
- A randomized trial of intravitreal bevacizumab vs. ranibizumab for myopic CNV(2015)
Authors: Alfredo Pece, Paolo Milani, Carla Monteleone, Costantino John Trombetta, Giuseppe De Crecchio, Giuseppe Fasolino, Domenica Matranga, Salvatore Cillino, Maria Vadalà
Pages: 1867-1872 - Is ranibizumab effective in stopping the loss of vision for choroidal neovascularisation in pathologic myopia?(2011)
Authors: Maria Vadalà, Alfredo Pece, Stefano Cipolla, Carla Monteleone, Giuseppe Fasolino, Alessandra Casuccio, Salvatore Cillino
Pages: 657-661